Cargando…

Single-Molecule Characterization of the Interactions between Extracellular Chaperones and Toxic α-Synuclein Oligomers

The aberrant aggregation of α-synuclein is associated with several human diseases, collectively termed the α-synucleinopathies, which includes Parkinson’s disease. The progression of these diseases is, in part, mediated by extracellular α-synuclein oligomers that may exert effects through several me...

Descripción completa

Detalles Bibliográficos
Autores principales:	Whiten, Daniel R., Cox, Dezerae, Horrocks, Mathew H., Taylor, Christopher G., De, Suman, Flagmeier, Patrick, Tosatto, Laura, Kumita, Janet R., Ecroyd, Heath, Dobson, Christopher M., Klenerman, David, Wilson, Mark R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cell Press 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024880/ https://www.ncbi.nlm.nih.gov/pubmed/29924993 http://dx.doi.org/10.1016/j.celrep.2018.05.074

Ejemplares similares

Quantifying Co-Oligomer Formation by α-Synuclein
por: Iljina, Marija, et al.
Publicado: (2018)

Mapping Surface Hydrophobicity of α-Synuclein Oligomers at the Nanoscale
por: Lee, Ji-Eun, et al.
Publicado: (2018)

Optical Structural Analysis of Individual α‐Synuclein Oligomers
por: Varela, Juan A., et al.
Publicado: (2018)

Single-molecule FRET studies on alpha-synuclein oligomerization of Parkinson’s disease genetically related mutants
por: Tosatto, Laura, et al.
Publicado: (2015)

Screening of small molecules using the inhibition of oligomer formation in α-synuclein aggregation as a selection parameter
por: Staats, Roxine, et al.
Publicado: (2020)

Alpha-Synuclein Oligomers Interact with Metal Ions to Induce Oxidative Stress and Neuronal Death in Parkinson's Disease
por: Deas, Emma, et al.
Publicado: (2016)

α-synuclein oligomers interact with ATP synthase and open the permeability transition pore in Parkinson’s disease
por: Ludtmann, Marthe H. R., et al.
Publicado: (2018)

Squalamine and Its Derivatives Modulate the Aggregation of Amyloid-β and α-Synuclein and Suppress the Toxicity of Their Oligomers
por: Limbocker, Ryan, et al.
Publicado: (2021)

Hsp70 Inhibits the Nucleation and Elongation of Tau and Sequesters Tau Aggregates with High Affinity
por: Kundel, Franziska, et al.
Publicado: (2018)

The Pathological G51D Mutation in Alpha-Synuclein Oligomers Confers Distinct Structural Attributes and Cellular Toxicity
por: Xu, Catherine K., et al.
Publicado: (2022)

PINK1 signalling in neurodegenerative disease
por: Whiten, Daniel R., et al.
Publicado: (2021)

Protease-activated alpha-2-macroglobulin can inhibit amyloid formation via two distinct mechanisms
por: Wyatt, Amy R., et al.
Publicado: (2013)

Real-time single-molecule observation of chaperone-assisted protein folding
por: Marzano, Nicholas R., et al.
Publicado: (2022)

Tumour necrosis factor induces increased production of extracellular amyloid-β- and α-synuclein-containing aggregates by human Alzheimer’s disease neurons
por: Whiten, Daniel R, et al.
Publicado: (2020)

Structural Characterization of Covalently Stabilized Human Cystatin C Oligomers
por: Chrabąszczewska, Magdalena, et al.
Publicado: (2020)

Ca(2+) is a key factor in α-synuclein-induced neurotoxicity
por: Angelova, Plamena R., et al.
Publicado: (2016)

Nanoscopic Characterisation of Individual Endogenous Protein Aggregates in Human Neuronal Cells
por: Whiten, Daniel R., et al.
Publicado: (2018)

Lipid peroxidation is essential for α‐synuclein‐induced cell death
por: Angelova, Plamena R., et al.
Publicado: (2015)

N-Terminal Acetylation of α-Synuclein Slows down Its Aggregation Process and Alters the Morphology of the Resulting Aggregates
por: Bell, Rosie, et al.
Publicado: (2022)

Exogenous misfolded protein oligomers can cross the intestinal barrier and cause a disease phenotype in C. elegans
por: Perni, Michele, et al.
Publicado: (2021)

Hsp70 chaperone blocks α-synuclein oligomer formation via a novel engagement mechanism
por: Tao, Jiahui, et al.
Publicado: (2021)

Using bicistronic constructs to evaluate the chaperone activities of heat shock proteins in cells
por: San Gil, Rebecca, et al.
Publicado: (2017)

The Interaction of αB-Crystallin with Mature α-Synuclein Amyloid Fibrils Inhibits Their Elongation
por: Waudby, Christopher A., et al.
Publicado: (2010)

Neuroserpin and transthyretin are extracellular chaperones that preferentially inhibit amyloid formation
por: West, Jennifer, et al.
Publicado: (2021)

Exosomal cell-to-cell transmission of alpha synuclein oligomers
por: Danzer, Karin M, et al.
Publicado: (2012)

Direct detection of alpha synuclein oligomers in vivo
por: Dimant, Hemi, et al.
Publicado: (2013)

The release of toxic oligomers from α-synuclein fibrils induces dysfunction in neuronal cells
por: Cascella, Roberta, et al.
Publicado: (2021)

The molecular chaperone Brichos breaks the catalytic cycle that generates toxic Aβ oligomers
por: Cohen, Samuel I. A., et al.
Publicado: (2015)

Lighting Up Alpha-synuclein Oligomers
por: Richter, Franziska
Publicado: (2018)

Alpha Synuclein only Forms Fibrils In Vitro when Larger than its Critical Size of 70 Monomers
por: Sanchez, Santiago Enrique, et al.
Publicado: (2021)

Secondary nucleation and elongation occur at different sites on Alzheimer’s amyloid-β aggregates
por: Scheidt, Tom, et al.
Publicado: (2019)

β-Synuclein suppresses both the initiation and amplification steps of α-synuclein aggregation via competitive binding to surfaces
por: Brown, James W. P., et al.
Publicado: (2016)

Chaperones as Suppressors of Protein Misfolded Oligomer Toxicity
por: Mannini, Benedetta, et al.
Publicado: (2017)

Extracellular Alpha-Synuclein Oligomers Induce Parkin S-Nitrosylation: Relevance to Sporadic Parkinson’s Disease Etiopathology
por: Wilkaniec, Anna, et al.
Publicado: (2018)

A mechanistic model of tau amyloid aggregation based on direct observation of oligomers
por: Shammas, Sarah L., et al.
Publicado: (2015)

An antibody scanning method for the detection of α-synuclein oligomers in the serum of Parkinson's disease patients
por: Kulenkampff, Klara, et al.
Publicado: (2022)

Alpha-synuclein oligomers: a new hope
por: Bengoa-Vergniory, Nora, et al.
Publicado: (2017)

The Role of α-Synuclein Oligomers in Parkinson’s Disease
por: Du, Xiao-yu, et al.
Publicado: (2020)

Stabilization of α-synuclein oligomers using formaldehyde
por: Ruesink, Harm, et al.
Publicado: (2019)

Single-molecule fluorescence-based approach reveals novel mechanistic insights into human small heat shock protein chaperone function
por: Johnston, Caitlin L., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_js37s6so9kgl8r7e1bueib3lvg